- Home
- MTVA vs CARV Comparison
MTVA vs CARV Comparison
Compare MTVA & CARV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTVA
- CARV
- Stock Information
- Founded
- MTVA 2014
- CARV 1948
- Country
- MTVA United States
- CARV United States
- Employees
- MTVA N/A
- CARV N/A
- Industry
- MTVA
- CARV Savings Institutions
- Sector
- MTVA
- CARV Finance
- Exchange
- MTVA NYSE
- CARV Nasdaq
- Market Cap
- MTVA 7.1M
- CARV 7.2M
- IPO Year
- MTVA N/A
- CARV 1994
- Fundamental
- Price
- MTVA $0.68
- CARV $1.37
- Analyst Decision
- MTVA Strong Buy
- CARV
- Analyst Count
- MTVA 1
- CARV 0
- Target Price
- MTVA $12.00
- CARV N/A
- AVG Volume (30 Days)
- MTVA 222.8K
- CARV 14.0K
- Earning Date
- MTVA 05-14-2025
- CARV 02-13-2025
- Dividend Yield
- MTVA N/A
- CARV N/A
- EPS Growth
- MTVA N/A
- CARV N/A
- EPS
- MTVA N/A
- CARV N/A
- Revenue
- MTVA N/A
- CARV $24,056,000.00
- Revenue This Year
- MTVA N/A
- CARV N/A
- Revenue Next Year
- MTVA N/A
- CARV N/A
- P/E Ratio
- MTVA N/A
- CARV N/A
- Revenue Growth
- MTVA N/A
- CARV N/A
- 52 Week Low
- MTVA $0.71
- CARV $1.30
- 52 Week High
- MTVA $5.30
- CARV $2.39
- Technical
- Relative Strength Index (RSI)
- MTVA N/A
- CARV 47.92
- Support Level
- MTVA N/A
- CARV $1.30
- Resistance Level
- MTVA N/A
- CARV $1.47
- Average True Range (ATR)
- MTVA 0.00
- CARV 0.08
- MACD
- MTVA 0.00
- CARV 0.01
- Stochastic Oscillator
- MTVA 0.00
- CARV 38.89
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.